The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer: A systematic review and meta-analysis
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F19%3A00536518" target="_blank" >RIV/60162694:G44__/19:00536518 - isvavai.cz</a>
Výsledek na webu
<a href="https://insights.ovid.com/crossref?an=00000658-201908000-00011" target="_blank" >https://insights.ovid.com/crossref?an=00000658-201908000-00011</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/SLA.0000000000003256" target="_blank" >10.1097/SLA.0000000000003256</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer: A systematic review and meta-analysis
Popis výsledku v původním jazyce
Objective: To define the influence of preoperative immune modulating nutrition (IMN) on postoperative outcomes in patients undergoing surgery for gastrointestinal cancer. Background: Although studies have shown that perioperative IMN may reduce postoperative infectious complications, the optimal timing of such an intervention is not clear. Methods: The Embase, Medline, and Cochrane databases were searched from 2000 to 2018, for prospective randomized controlled trials evaluating preoperative oral or enteral IMN in patients undergoing surgery for gastrointestinal cancer. Results: Sixteen studies reporting on 1387 patients (715 IMN group, 672 control group) were included. Preoperative IMN in patients undergoing surgery for gastrointestinal cancer reduced infectious complications [odds ratio (OR) 0.52, 95% confidence interval (CI) 0.38-0.71, P < 0.0001, I2 ¼ 16%, n ¼ 1387] and length of hospital stay (weighted mean difference 1.57 days, 95% CI 2.48 to 0.66, P ¼ 0.0007, I2 ¼ 34%, n ¼ 995).Conclusion: Preoperative IMN should be encouraged in routine practice.
Název v anglickém jazyce
The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer: A systematic review and meta-analysis
Popis výsledku anglicky
Objective: To define the influence of preoperative immune modulating nutrition (IMN) on postoperative outcomes in patients undergoing surgery for gastrointestinal cancer. Background: Although studies have shown that perioperative IMN may reduce postoperative infectious complications, the optimal timing of such an intervention is not clear. Methods: The Embase, Medline, and Cochrane databases were searched from 2000 to 2018, for prospective randomized controlled trials evaluating preoperative oral or enteral IMN in patients undergoing surgery for gastrointestinal cancer. Results: Sixteen studies reporting on 1387 patients (715 IMN group, 672 control group) were included. Preoperative IMN in patients undergoing surgery for gastrointestinal cancer reduced infectious complications [odds ratio (OR) 0.52, 95% confidence interval (CI) 0.38-0.71, P < 0.0001, I2 ¼ 16%, n ¼ 1387] and length of hospital stay (weighted mean difference 1.57 days, 95% CI 2.48 to 0.66, P ¼ 0.0007, I2 ¼ 34%, n ¼ 995).Conclusion: Preoperative IMN should be encouraged in routine practice.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30212 - Surgery
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2019
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Annals of Surgery
ISSN
0003-4932
e-ISSN
1528-1140
Svazek periodika
270
Číslo periodika v rámci svazku
2
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
10
Strana od-do
247-256
Kód UT WoS článku
000480739600063
EID výsledku v databázi Scopus
2-s2.0-85069813282